Subscribe To Our Free Newsletter |
Glenmark Q3 Results: Co reports net loss of Rs 351 cr on lower domestic sales
Total revenue from operations declined to Rs 2,507 crore as compared with Rs 3,100 crore in the year-ago period, Glenmark Pharma said in a statement.